General Outcome Measurements: DN4 Questionnaire

Pain can have different contributing mechanisms. Some pain presentations may include features commonly associated with neuropathic pain, such as burning, electric shocks, tingling, pins and needles, numbness, itching or altered sensation.

The DN4 was developed to help distinguish neuropathic pain features from non-neuropathic pain features using a short set of symptom and examination items.

It is commonly used in:

• persistent pain assessment
• nerve-related symptom screening
• diabetic neuropathy research
• post-surgical pain research
• radicular pain contexts
• chronic pain settings
• referral-support documentation

The DN4 is useful because it combines symptom descriptors with simple sensory examination findings. However, it should still be interpreted as a screening tool, not a stand-alone diagnosis.

Quick Summary

• Outcome measure: Douleur Neuropathique 4 Questions
• Abbreviation: DN4
• Category: Neuropathic pain screening questionnaire
• Type: Client-reported symptoms plus sensory examination
• Number of items: 10
• Score range: 0–10
• Common cut-off: 4 or more out of 10
• Higher score means: More neuropathic pain features reported or observed
• Lower score means: Fewer neuropathic pain features
• Best used for: Screening for neuropathic pain features
• Key limitation: DN4 does not diagnose neuropathic pain or identify the cause on its own

What Is the DN4 Questionnaire?

The DN4 is a 10-item screening questionnaire.

It includes items related to:

• burning
• painful cold
• electric shocks
• tingling
• pins and needles
• numbness
• itching
• hypoesthesia to touch
• hypoesthesia to pinprick
• pain caused or increased by brushing

The first seven items are based on the client’s symptoms.

The final three items are based on simple sensory examination.

Each item is scored:

• Yes = 1
• No = 0

The total score ranges from 0 to 10.

A score of 4 or more is commonly used as a positive screening result.

Why It Is Used

The DN4 is used because neuropathic pain features may influence assessment reasoning, referral decisions and management planning.

A client may describe symptoms such as:

• burning pain
• electric-shock sensations
• tingling
• pins and needles
• numbness
• itching
• altered sensitivity
• pain from light touch
• unusual cold pain
• sensory changes

The DN4 may help professionals:

• identify neuropathic pain features
• support referral-aware screening
• document symptom descriptors
• guide further neurological or medical assessment where appropriate
• compare symptoms over time
• avoid relying only on pain intensity
• improve communication about sensory symptoms

The DN4 should be interpreted alongside history, neurological findings, symptom distribution, medical history, physical assessment and professional judgement.

What It Measures

The DN4 measures features commonly associated with neuropathic pain.

It may provide insight into:

• sensory descriptors
• altered sensation
• allodynia-like symptoms
• hypoesthesia to touch
• hypoesthesia to pinprick
• neuropathic pain feature burden
• whether further assessment may be needed

It does not directly measure:

• diagnosis
• nerve lesion
• nerve disease
• imaging findings
• nerve conduction
• tissue damage
• pain mechanism with certainty
• severity of injury
• sport readiness
• work readiness

Who It Is Useful For

The DN4 may be useful for:

• rehabilitation practitioners
• allied health support teams
• exercise professionals working within scope
• pain-informed movement professionals
• movement assessment professionals
• students learning screening tools
• professionals documenting sensory symptom features

It may be relevant for clients with:

• burning pain
• electric-shock pain
• numbness
• tingling
• pins and needles
• altered skin sensitivity
• pain after nerve injury
• diabetic neuropathy features
• radicular or radiating symptoms
• post-surgical sensory symptoms
• persistent pain with sensory descriptors

When to Use This Questionnaire

Use the DN4 when you want to screen whether pain has neuropathic features.

It may be useful at:

• initial assessment
• baseline pain screening
• reassessment
• persistent pain review
• neurological symptom documentation
• referral-support discussion
• progress monitoring where neuropathic features are relevant

The DN4 is especially useful when the client describes sensory symptoms rather than only aching, soreness or mechanical pain.

When Not to Use or When to Be Cautious

Use caution when:

• neurological symptoms are severe or worsening
• red flags are present
• symptoms are new, unexplained or rapidly progressing
• the client cannot understand the descriptors
• the professional is not trained to perform sensory testing
• the result is being used as a diagnosis
• the score is interpreted without broader assessment

The DN4 should not be used to:

• diagnose neuropathic pain on its own
• confirm a nerve lesion or disease
• replace neurological assessment
• replace medical assessment
• explain symptoms on its own
• determine treatment need
• clear someone for sport
• clear someone for work
• replace professional judgement

Equipment or Resources Required

You need:

• DN4 questionnaire
• scoring instructions
• appropriate sensory testing materials
• symptom notes
• body chart or symptom map
• baseline and retest dates

For sensory testing, the original DN4 includes touch and pinprick-related items. Professionals should only perform sensory testing that is appropriate to their training, setting and scope.

Administration Protocol / Practice

Setup

Explain the purpose of the questionnaire before starting.

Example wording:

“This questionnaire checks whether your pain has features commonly seen with neuropathic or nerve-related pain. It does not diagnose the cause, but it can help us decide whether further assessment may be useful.”

Format

The DN4 includes:

• symptom questions
• sensory examination items

It can be completed as part of a structured pain assessment.

Client Instructions

Ask the client to:

• answer based on the pain being assessed
• focus on the main painful area
• describe whether each symptom is present or absent
• ask for clarification if they do not understand a descriptor
• report any unusual or uncomfortable responses during sensory testing

Scoring Process

Each item is scored:

• Yes = 1
• No = 0

Total score range:

• 0–10

A score of 4 or more out of 10 is commonly used as a positive screening result.

Retesting Considerations

Retest when useful, such as:

• baseline
• reassessment
• after symptom change
• after a flare-up
• during persistent pain monitoring
• before referral review
• progress review

For consistency, record the same pain area, same version, symptom distribution, sensory testing method and current symptom context.

Safety Notes

The DN4 includes sensory testing. Testing should be gentle and appropriate.

If the client reports worsening neurological symptoms, progressive weakness, bowel or bladder changes, saddle symptoms, severe unexplained pain or other red flags, further assessment or urgent referral may be required.

Scoring and Interpretation

The DN4 score ranges from 0 to 10.

Higher scores indicate more neuropathic pain features.

Lower scores indicate fewer neuropathic pain features.

A commonly used cut-off is:

• 4 or more out of 10: positive screening result for neuropathic pain features

This cut-off should not be treated as a stand-alone diagnosis.

What a High Score May Suggest

A higher DN4 score may suggest:

• more neuropathic pain descriptors
• sensory changes
• possible neuropathic pain component
• need for further neurological or medical assessment
• value in documenting symptom distribution
• referral consideration where appropriate

A high score does not prove neuropathic pain.

What a Low Score May Suggest

A lower DN4 score may suggest fewer neuropathic pain features.

A low score does not fully exclude neuropathic pain, especially if symptoms are intermittent, the wrong pain area is assessed, the client has difficulty describing symptoms or sensory testing is incomplete.

What the Score Does Not Prove

A DN4 score does not prove:

• diagnosis
• nerve lesion
• nerve disease
• pain mechanism with certainty
• imaging findings
• tissue damage
• symptom cause
• treatment need
• sport readiness
• work readiness

How to Explain the Result Safely

Example wording:

“Your DN4 result shows whether your pain has features commonly associated with neuropathic pain. It does not diagnose the cause, but it helps us decide whether further assessment or referral may be useful.”

What the Score May Mean in Different Client Populations

General Fitness Clients

For general fitness clients, DN4 may help identify whether sensory descriptors are relevant to their pain presentation.

Interpretation should include training history, symptom distribution and neurological screening where appropriate.

Sport and Performance Clients

For athletes, neuropathic features may affect training tolerance, contact exposure, confidence and recovery.

DN4 should not be used to determine sport readiness on its own.

Older Adults

For older adults, interpretation should consider diabetes, medication context, comorbidities, balance, sensory loss, neurological history and general health.

Youth Clients

For youth clients, consider comprehension, descriptor understanding and whether the measure is appropriate.

If assistance is provided, record it clearly.

Clients With Persistent Pain

For persistent pain, the DN4 may help identify neuropathic features within a broader pain presentation.

It should be combined with physical assessment, symptom history and referral-aware reasoning.

Clients With Diabetes or Known Neurological Conditions

In clients with diabetes or known neurological conditions, DN4 may help document neuropathic features but should not replace medical assessment or neurological testing where indicated.

Meaningful Change, MCID, MDC and Responsiveness

The DN4 is primarily a screening questionnaire, not a typical progress outcome measure.

High-quality, universally applicable MCID or MDC values are not usually used in the same way as disability questionnaires.

DN4 change should be interpreted with:

• baseline comparison
• symptom descriptor change
• sensory findings
• pain intensity
• function change
• medical context
• neurological findings
• professional judgement

A change from positive to negative screening status may be useful context, but it does not prove that a neuropathic mechanism has resolved.

Normative Data, Reference Values or Comparative Data

The DN4 is not usually interpreted using general population norms.

It is commonly interpreted using the cut-off score of 4 or more out of 10.

Performance may vary by:

• pain condition
• language version
• clinical setting
• presence of sensory examination
• pain distribution
• disease context
• assessor training
• population being screened

Practical comparison guidance:

• use the same version at retest
• assess the same pain area
• interpret the cut-off as screening only
• combine the score with neurological and medical context
• avoid using DN4 as a pass/fail diagnosis

Reliability and Validity

The original DN4 validation study reported strong diagnostic accuracy for distinguishing neuropathic from non-neuropathic pain in the studied sample.

The questionnaire has since been translated and validated across multiple languages and clinical populations.

Evidence generally supports DN4 as a useful neuropathic pain screening tool, but performance varies across populations and settings.

Reliability and validity are strongest when:

• the correct version is used
• symptom descriptors are clearly explained
• sensory examination items are performed appropriately
• the pain area being assessed is clear
• the result is interpreted with history and examination findings
• the score is used as screening rather than diagnosis

Interpret cautiously when:

• sensory testing is not performed
• the client has difficulty understanding descriptors
• symptoms are intermittent
• pain is widespread or mixed-mechanism
• neurological symptoms are rapidly changing
• the score is used as a stand-alone diagnosis

Common Errors and Limitations

Common errors include:

• treating DN4 as a definitive diagnosis
• using the cut-off without broader assessment
• not clarifying the pain area being assessed
• skipping sensory examination without noting it
• ignoring red flags
• ignoring neurological progression
• assuming all tingling equals neuropathic pain
• using DN4 to determine treatment or clearance alone

Limitations include:

• screening tool only
• score performance varies by population
• sensory testing requires appropriate training
• symptom descriptors may be misunderstood
• neuropathic and non-neuropathic features can overlap
• mixed pain mechanisms are common
• it does not identify the cause of symptoms
• it should not replace medical or neurological assessment where needed

Practical Applications

The DN4 may help professionals:

• document neuropathic pain features
• support referral-aware reasoning
• identify sensory descriptors
• compare symptom features over time
• guide further assessment decisions
• communicate pain features more clearly
• avoid relying only on pain intensity

For active clients, DN4 may help clarify whether symptoms such as burning, electric shocks, numbness or tingling should be considered during training modification or referral discussion.

For persistent pain clients, it can help document whether neuropathic features are part of a broader pain presentation.

FAQs

What does the DN4 measure?

The DN4 screens for symptoms and sensory findings commonly associated with neuropathic pain.

How many items are in the DN4?

The DN4 has 10 items.

How is the DN4 scored?

Each item is scored Yes = 1 and No = 0. The total score ranges from 0 to 10.

What is the DN4 cut-off?

A score of 4 or more out of 10 is commonly used as a positive screening result.

Does DN4 diagnose neuropathic pain?

No. DN4 is a screening tool and does not diagnose neuropathic pain on its own.

What symptoms does DN4 ask about?

It asks about symptoms such as burning, painful cold, electric shocks, tingling, pins and needles, numbness and itching.

Does DN4 include physical examination?

Yes. The full DN4 includes sensory examination items related to touch, pinprick and brushing.

Should DN4 be used alone?

No. It should be combined with history, symptom distribution, neurological findings, physical assessment and professional judgement.

Key Takeaways

• DN4 is a 10-item neuropathic pain screening questionnaire.
• It includes symptom descriptors and sensory examination items.
• Scores range from 0 to 10.
• A score of 4 or more is commonly used as a positive screening result.
• DN4 does not diagnose neuropathic pain on its own.
• It should be interpreted alongside history, neurological findings and broader assessment.
• Red flags or worsening neurological symptoms require appropriate referral or escalation.

References

Bouhassira, D., Attal, N., Alchaar, H., Boureau, F., Brochet, B., Bruxelle, J., Cunin, G., Fermanian, J., Ginies, P., Grun-Overdyking, A., Jafari-Schluep, H., Lantéri-Minet, M., Laurent, B., Mick, G., Serrie, A., Valade, D., & Vicaut, E. (2005). Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain, 114(1–2), 29–36. https://doi.org/10.1016/j.pain.2004.12.010

Spallone, V., Morganti, R., D’Amato, C., Greco, C., Cacciotti, L., & Marfia, G. A. (2012). Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabetic Medicine, 29(5), 578–585. https://doi.org/10.1111/j.1464-5491.2011.03500.x

Timmerman, H., Steegers, M. A. H., Huygen, F. J. P. M., Goeman, J. J., van Dasselaar, N. T., Schenkels, M., Wilder-Smith, O. H. G., Wolff, A. P., & Vissers, K. C. P. (2017). Investigating the validity of the DN4 in a consecutive population of patients with chronic pain. PLOS ONE, 12(11), e0187961. https://doi.org/10.1371/journal.pone.0187961

Van Seventer, R., Vos, C., Giezeman, M., Meerding, W. J., Arnould, B., Regnault, A., van Eerd, M., Martin, C., & Huygen, F. J. P. M. (2013). Validation of the Dutch version of the DN4 diagnostic questionnaire for neuropathic pain. Pain Practice, 13(5), 390–398. https://doi.org/10.1111/j.1533-2500.2012.00558.x